News

The author has always thought that advanced machines could not replace humans - until recently.

After enduring a week-long 21.2% pay cut, ophthalmologists and other physicians who see Medicare patients will receive a 2.2% pay increase, retroactive to June 1 through Nov. 30.

A surgical microscope (OPMI Lumera 700, Carl Zeiss Meditec) has received a "red dot design award" in product design from a 30-member international jury of the Design Zentrum Nordrhein Westfalen, Essen, Germany.

Bausch + Lomb has purchased the assets and U.S. rights for ganciclovir ophthalmic gel 0.15% (Zirgan) from Sirion Therapeutics Inc., announced Bausch + Lomb in a press release.

Gatifloxacin ophthalmic solution 0.5% (Zymaxid, Allergan) is expected to be available to U.S. physicians and patients this month, according to the manufacturer.

Bromfenac ophthalmic solution 0.09% is effective for preventing pseudophakic cystoid macular edema when instilled 3 days before phacoemulsification and IOL implantation and then following surgery.

Ketorolac tromethamine ophthalmic solution 0.45%, a third-generation formulation of the nonsteroidal anti-inflammatory drug, had a highly beneficial effect on visual acuity after cataract surgery in a recent study.

A post hoc analysis of data collected in two published, pivotal clinical trials demonstrates that in addition to its efficacy for treating inflammation following ocular surgery, loteprednol etabonate ophthalmic suspension 0.5% provides statistically significant relief of postoperative pain and other symptoms.

Pre- and postoperative treatment with the potent corticosteroid difluprednate ophthalmic solution 0.05% significantly improves outcomes after cataract surgery compared with use of prednisolone acetate ophthalmic suspension 1% and so results in patient satisfaction.

In a quantitative determination of the prophylactic effectiveness of two commercially available ocular fluoroquiinolones within the anterior chamber of rabbit eyes, moxifloxacin ophthalmic solution 0.5% demonstrated significantly greater bacterial killing than besifloxacin ophthalmic suspension 0.6%.

As yet another deadline challenges Congress to avert a 21.3% pay cut to physicians who treat Medicare and Medicaid patients, groups representing the nation's physicians say they do not support a proposal that fails to change the formula behind the cut.

The availability of a new formulation of gatifloxacin ophthalmic solution containing 0.5% active ingredient will provide ophthalmologists with a valuable option for addressing the growing problem of resistance among some important ocular pathogens.

In a study performed to evaluate and compare preserved versus unpreserved fluoroquinolone antibiotics, cell culture assays demonstrated some degree of toxicity and elevated induction of apoptosis in each of three commercially available topical ocular fluoroquinolone antibiotics.

Data from 1 year of follow-up in a 2-year study demonstrate a favorable clinical performance of a microincisional IOL designed for implantation through a 1.8 mm incision.